Bausch + Lomb Corporation (BLCO)

Market Cap	6.34B
Revenue (ttm)	4.68B
Net Income (ttm)	-368.00M
Shares Out	352.17M
EPS (ttm)	-1.05
PE Ratio	n/a
Forward PE	22.42
Dividend	n/a
Ex-Dividend Date	n/a

Volume	399,560
Open	17.85
Previous Close	17.95
Day's Range	17.85 - 18.20
52-Week Range	13.16 - 21.69
Beta	0.43
Analysts	Buy
Price Target	20.91 (+16.17%)
Earnings Date	Oct 30, 2024

About BLCO

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: May 6, 2022
• Employees: 13,300
• Stock Exchange: NYSE
• Ticker Symbol: BLCO
• Website: https://www.bausch.com

Analyst Forecast

According to 12 analysts, the average rating for BLCO stock is "Buy." The 12-month stock price forecast is $20.91, which is an increase of 16.17% from the latest price.

Price Target

$20.91

(16.17% upside)

Analyst Consensus: Buy